Drug Trial Radar · NCT04349800
A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 (Sebetralstat) in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
Jan 4, 2018
Primary completion
Sep 10, 2018
Study completion Sep 10, 2018
Sponsor
- Lead sponsor
- KalVista Pharmaceuticals, Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 16, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A safety, tolerability, pharmacokinetic and food effect study of KVD900 in healthy volunteers.
Conditions
- Hereditary Angioedema
Interventions
KVD900Drug
Active
Placebo to KVD900Drug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects with Adverse EventsTime frame: Change from pre-dose to last visit, 5-7 days post dose.
- Number of Subjects with Serious Adverse EventsTime frame: Change from pre-dose to last visit, 5-7 days post dose.
- Number of participants with clinically significant changes in laboratory assessmentsTime frame: Throughout study until last visit, 5-7 days post dose.
- Number of participants with clinically significant changes in vital signsTime frame: Throughout study until last visit, 5-7 days post dose.
- Number of participants with clinically significant changes in electrocardiogram (ECG) measurementsTime frame: Throughout study until last visit, 5-7 days post dose.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
KalVista Investigative Site
Wales, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.